Aubhishek Zaman, PhD
Associate Specialist
Computational Health Scienc
School of Medicine

Websites

Show all (1) Hide

• Google Scholar (scholar.google.com)

Publications (11)

Top publication keywords:
Esophageal NeoplasmsAPOBEC-3G DeaminaseVirusesNeurofibromin 1Guanosine TriphosphateHepatocyte Growth FactorCytosolProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins B-rafral GTP-Binding ProteinseIF-2 KinaseBiomarkers, TumorNeoplasmsMultiprotein ComplexesTOR Serine-Threonine Kinases

• Quantitative Framework for Bench-to-Bedside Cancer Research.
  Cancers 2022 Zaman A, Bivona TG
• Targeting AXL in NSCLC.
  Lung Cancer (Auckland, N.Z.) 2021 Zaman A, Bivona TG
• Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote virus detection and cancer.
  Cell reports 2021 Zaman A, Wu X, Lemoff A, Yadavalli S, Lee J, Wang C, Cooper J, McMillan EA, Yeaman C, Mirzaei H, White MA, Bivona TG
• Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G.
  Cancer letters 2020 Liu J, Mayekar MK, Wu W, Yan M, Guan H, Wang J, Zaman A, Cui Y, Bivona TG, Choudhry H, Xing Q, Cao W
• Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma.
  Nature communications 2020 Cao W, Lee H, Wu W, Zaman A, McCorkle S, Yan M, Chen J, Xing Q, Sinnott-Armstrong N, Xu H, Sailani MR, Tang W, Cui Y, Liu J, Guan H, Lv P, Sun X, Sun L, Han P, Lou Y, Chang J, Wang J, Gao Y, Guo J, …

Show all (6 more) Hide

• Targeting Oncogenic BRAF: Past, Present, and Future.
  Cancers 2019 Zaman A, Wu W, Bivona TG
• RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers.
  Nature cell biology 2018 Nichols RJ, Haderk F, Stahlhut C, Schulze CJ, Hemmati G, Wildes D, Tzitzilonis C, Mordec K, Marquez A, Romero J, Hsieh T, Zaman A, Olivas V, McCoach C, Blakely CM, Wang Z, Kiss G, Koltun ES, Gill AL, …
• Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.
  Annals of translational medicine 2018 Zaman A, Bivona TG
• TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.
  Cancer research 2017 Cooper JM, Ou YH, McMillan EA, Vaden RM, Zaman A, Bodemann BO, Makkar G, Posner BA, White MA
• Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.
  Cancer discovery 2017 Eskiocak B, McMillan EA, Mendiratta S, Kollipara RK, Zhang H, Humphries CG, Wang C, Garcia-Rodriguez J, Ding M, Zaman A, Rosales TI, Eskiocak U, Smith MP, Sudderth J, Komurov K, Deberardinis RJ, …
• Role of the Exocyst Complex Component Sec6/8 in Genomic Stability.
  Molecular and cellular biology 2015 Torres MJ, Pandita RK, Kulak O, Kumar R, Formstecher E, Horikoshi N, Mujoo K, Hunt CR, Zhao Y, Lum L, Zaman A, Yeaman C, White MA, Pandita TK